Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun Fan

Showing results (771-780 of 920) with videos related to

Pageof 92
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|January 24, 2017
Controlled Encapsulation of Functional Organic Molecules within Metal-Organic Frameworks: In Situ Crystalline Structure TransformationJinju Guan, Yu Hu, Yu Wang, et al.
Bioscience Reports|August 22, 2019
FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathwaysNanwen Zhang, Zhiwei Liu, Hongbin Luo, et al.
The Lancet. Oncology|January 5, 2025
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trialYanjun Xu, Kaiyan Chen, Yujin Xu, et al.
International Journal of Cancer|November 24, 2020
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China StudyYi-Long Wu, Li Zhang, Yun Fan, et al.
International Journal of Cancer|November 6, 2025
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studiesSizhe Yu, Hui Li, Hongyang Lu, et al.
Nature Communications|January 30, 2024
Molecular mechanisms underlying the BIRC6-mediated regulation of apoptosis and autophagyShuo-Shuo Liu, Tian-Xia Jiang, Fan Bu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2011
Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis BEdward J Gane, Yuming Wang, Yun-Fan Liaw, et al.
Hepatology (Baltimore, Md.)|August 20, 2025
Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolutionKai-Qian Zhou, Yu-Chen Zhong, Min-Fang Song, et al.
Cancer|June 7, 2023
Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancerQing Zhou, Jun Zhao, Jianhua Chang, et al.
Hepatology (Baltimore, Md.)|December 10, 2024
Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolutionKai-Qian Zhou, Yu-Chen Zhong, Min-Fang Song, et al.
Pageof 92

Showing results (771-780 of 920) with videos related to

Sort By:
Pageof 92
Advanced Materials (Deerfield Beach, Fla.)|January 24, 2017
Controlled Encapsulation of Functional Organic Molecules within Metal-Organic Frameworks: In Situ Crystalline Structure TransformationJinju Guan, Yu Hu, Yu Wang, et al.
Bioscience Reports|August 22, 2019
FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathwaysNanwen Zhang, Zhiwei Liu, Hongbin Luo, et al.
The Lancet. Oncology|January 5, 2025
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trialYanjun Xu, Kaiyan Chen, Yujin Xu, et al.
International Journal of Cancer|November 24, 2020
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China StudyYi-Long Wu, Li Zhang, Yun Fan, et al.
International Journal of Cancer|November 6, 2025
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studiesSizhe Yu, Hui Li, Hongyang Lu, et al.
Nature Communications|January 30, 2024
Molecular mechanisms underlying the BIRC6-mediated regulation of apoptosis and autophagyShuo-Shuo Liu, Tian-Xia Jiang, Fan Bu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2011
Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis BEdward J Gane, Yuming Wang, Yun-Fan Liaw, et al.
Hepatology (Baltimore, Md.)|August 20, 2025
Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolutionKai-Qian Zhou, Yu-Chen Zhong, Min-Fang Song, et al.
Cancer|June 7, 2023
Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancerQing Zhou, Jun Zhao, Jianhua Chang, et al.
Hepatology (Baltimore, Md.)|December 10, 2024
Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolutionKai-Qian Zhou, Yu-Chen Zhong, Min-Fang Song, et al.
Pageof 92